Organogenesis Holdings Inc.
ORGO
Revenue
130.23M
▲20.26M▲18.42%
3 Months ChangeAssets
443.16M
▼-15.32M▼-3.34%
3 Months ChangeLiabilities
179.66M
▼-789.00k▼-0.4372%
3 Months ChangeFree Cash Flow
-12.38M
▲255.00k▲2.02%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-094009
2024-08-08
Form 8-K
ID: 0000950170-24-093893
2024-06-21
Form 8-K
ID: 0001193125-24-165670
2024-05-09
Form 10-Q
ID: 0000950170-24-057050
2024-05-09
Form 8-K
ID: 0000950170-24-056885
2024-04-03
Form 8-K
ID: 0001193125-24-086129
2024-02-29
Form 8-K
ID: 0000950170-24-023059
2023-11-09
Form 10-Q
ID: 0000950170-23-062056
2023-11-09
Form 8-K
ID: 0000950170-23-062041
2023-08-09
Form 10-Q
ID: 0000950170-23-040670